IRIS Accounts Production v23.3.1.45 11099874 director 30.3.22 28.3.23 28.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh110998742022-03-29110998742023-03-28110998742022-03-302023-03-28110998742021-03-30110998742021-03-312022-03-29110998742022-03-2911099874ns10:Originalns15:EnglandWales2022-03-302023-03-2811099874ns14:PoundSterlingns10:Original2022-03-302023-03-2811099874ns10:Originalns10:Director12022-03-302023-03-2811099874ns10:Original2022-03-302023-03-2811099874ns10:Original2023-03-2811099874ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-302023-03-2811099874ns10:Originalns10:SmallEntities2022-03-302023-03-2811099874ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-302023-03-2811099874ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-302023-03-2811099874ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-302023-03-2811099874ns10:Originalns10:FullAccounts2022-03-302023-03-2811099874ns10:Originalns10:RegisteredOffice2022-03-302023-03-2811099874ns10:Original2022-03-2911099874ns10:Originalns5:CurrentFinancialInstruments2023-03-2811099874ns10:Originalns5:CurrentFinancialInstruments2022-03-2911099874ns10:Originalns5:Non-currentFinancialInstruments2023-03-2811099874ns10:Originalns5:Non-currentFinancialInstruments2022-03-2911099874ns5:ShareCapitalns10:Original2023-03-2811099874ns5:ShareCapitalns10:Original2022-03-2911099874ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-2811099874ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-2911099874ns10:Originalns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-03-302023-03-2811099874ns10:Originalns5:PlantMachinery2022-03-302023-03-2811099874ns10:Original2021-03-312022-03-2911099874ns10:Originalns5:LandBuildings2022-03-2911099874ns10:Originalns5:PlantMachinery2022-03-2911099874ns10:Original2022-03-2911099874ns10:Originalns5:LandBuildings2022-03-302023-03-2811099874ns10:Originalns5:LandBuildings2023-03-2811099874ns10:Originalns5:PlantMachinery2023-03-2811099874ns10:Originalns5:LandBuildings2022-03-2911099874ns10:Originalns5:PlantMachinery2022-03-2911099874ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-2811099874ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-29
REGISTERED NUMBER: 11099874 (England and Wales)










Unaudited Financial Statements

for the Period 30 March 2022 to 28 March 2023

for

Medispace UK Limited

Medispace UK Limited (Registered number: 11099874)






Contents of the Financial Statements
for the Period 30 March 2022 to 28 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Medispace UK Limited

Company Information
for the Period 30 March 2022 to 28 March 2023







DIRECTOR: Mr I J Craggs





REGISTERED OFFICE: Unit 4 Enterprise Court
Queens Meadow Business Park
Hartlepool
Co. Durham
TS25 2FE





REGISTERED NUMBER: 11099874 (England and Wales)





ACCOUNTANTS: Haines Watts
Military House
24 Castle Street
Chester
Cheshire
CH1 2DS

Medispace UK Limited (Registered number: 11099874)

Balance Sheet
28 March 2023

28.3.23 29.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 39,263 41,074

CURRENT ASSETS
Debtors 5 4,614 -
Cash at bank 261 2,175
4,875 2,175
CREDITORS
Amounts falling due within one year 6 173,286 149,286
NET CURRENT LIABILITIES (168,411 ) (147,111 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(129,148

)

(106,037

)

CREDITORS
Amounts falling due after more than one
year

7

(42,850

)

(42,500

)

PROVISIONS FOR LIABILITIES - (3,337 )
NET LIABILITIES (171,998 ) (151,874 )

CAPITAL AND RESERVES
Called up share capital 300 300
Retained earnings (172,298 ) (152,174 )
(171,998 ) (151,874 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 March 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medispace UK Limited (Registered number: 11099874)

Balance Sheet - continued
28 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 March 2024 and were signed by:





Mr I J Craggs - Director


Medispace UK Limited (Registered number: 11099874)

Notes to the Financial Statements
for the Period 30 March 2022 to 28 March 2023

1. STATUTORY INFORMATION

Medispace UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling, which is the functional currency of the company, rounded to the nearest £1.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 10% on cost
Plant and machinery - 25% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
At the year end the company's liabilities exceeded its assets by £171,998 and as such the company's ability to continue to operate depends on the support of its Director. The Financial Statements have been prepared on a going concern basis as the Director intends to give their support for the foreseeable future.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2022 - 1 ) .

Medispace UK Limited (Registered number: 11099874)

Notes to the Financial Statements - continued
for the Period 30 March 2022 to 28 March 2023

4. TANGIBLE FIXED ASSETS
Freehold Plant and
property machinery Totals
£    £    £   
COST
At 30 March 2022 33,647 16,668 50,315
Additions - 2,159 2,159
At 28 March 2023 33,647 18,827 52,474
DEPRECIATION
At 30 March 2022 2,240 7,001 9,241
Charge for period 1,014 2,956 3,970
At 28 March 2023 3,254 9,957 13,211
NET BOOK VALUE
At 28 March 2023 30,393 8,870 39,263
At 29 March 2022 31,407 9,667 41,074

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.3.23 29.3.22
£    £   
Trade debtors 970 -
Other debtors 3,644 -
4,614 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.3.23 29.3.22
£    £   
Bank loans and overdrafts 6,600 7,500
Trade creditors 1,211 2,298
Other creditors 165,475 139,488
173,286 149,286

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
28.3.23 29.3.22
£    £   
Bank loans 42,850 42,500

8. RELATED PARTY DISCLOSURES

The director has loaned to the company a total of £49,097 in the year and has been a repaid a total of £18,141. The balance outstanding to the director as at 28.03.2024 is £161,240 (2022 - £130,284)